In the Boardroom
Refine Search
Pharmaceutical
All eyes were on the share price of Swiss pharma giant Novartis on Monday after the announcement that Joe Jimenez was to step down from his role as chief executive. 4 September 2017
Generics
Bain Capital and Cinven announce their intention to nominate Claudio Albrecht as new chief executive and Mark Keatley as new chief financial officer of Stada Arzneimittel, the German generic drugmaker they are in the process of acquiring. 4 September 2017
Pharmaceutical
German family-owned pharma company Grünenthal Group today announces that Mark Fladrich has taken office as new chief commercial officer (CCO). 1 September 2017
Pharmaceutical
Following the succession plan initiated more than a year ago, when Eduardo Sanchiz expressed his wish to devote more time to his family and other interests, the board of directors of Spain’s largest pharma firm Almirall has approved the appointment of Peter Guenter as chief executive effective Octoberjavascript:void(0); 1, 2017. 29 August 2017
Pharmaceutical
Switzerland’s Novartis has appointed Bertrand Bodson as chief digital officer, reporting directly to the CEO. 24 August 2017
Pharmaceutical
Almirall has appointed Ron Menezes as the new president and general manager of its USA-based subsidiary Aqua Pharmaceuticals. 22 August 2017
Biotechnology
UK-based artificial intelligence firm BenevolentAI has hired Ian Churcher as VP of drug discovery & preclinical development for its bioscience subsidiary, BenevolentBio. 22 August 2017
Biotechnology
Ireland-headquartered Shire has announced changes to its executive committee, as it progresses its strategy to sharpen its focus as a leader in rare diseases. 21 August 2017
Pharmaceutical
UK-registered Akari Therapeutics has appointed Dr David Horn Solomon as the company’s new chief executive, effective August 28, 2017. 21 August 2017
Pharmaceutical
Danish diabetes giant Novo Nordisk has announced two changes to its executive team. 15 August 2017
Pharmaceutical
Merz Neuroscience, a division of Merz North America, today announced that Kevin O’Brien will join the company as the vice president and US head of neurosciences, effective immediately. 15 August 2017
Biotechnology
UK and USA-based clinical-stage biotech Orchard Therapeutics today announces the appointment of Mark Rothera as president and chief executive. 10 August 2017
Pharmaceutical
It seemed inevitable that change was on the horizon when Emma Walmsley’s appointment as chief executive of UK pharma major GlaxoSmithKline, taking over from Sir Andrew Witty, was announced nearly a year ago. 7 August 2017
Biotechnology
Dutch human gene therapy specialist uniQure has made several new executive appointments. 7 August 2017
Biotechnology
US clinical-stage biotech firm Pfenex today announced the appointment of Evert (Eef) Schimmelpennink as chief executive, president, and secretary effective August 3, 2017. 3 August 2017
Biotechnology
Norwegian non-Hodgkin’s Lymphoma specialist Nordic Nanovector has appointed a new head of medical affairs, Reza Safaei. 2 August 2017
Biotechnology
Anabella Villalobos has been appointed as senior vice president, Biotherapeutic & Medicinal Sciences (BTMS), at US biotech major Biogen. 1 August 2017
Biotechnology
AstraZeneca and its research arm MedImmune, today announced the appointment of two internationally-recognized immuno-oncology leaders. 31 July 2017
Biotechnology
Alisha Alaimo has been appointed senior vice president of US Therapeutic Operations at US biotech major Biogen. 25 July 2017
Pharmaceutical
Trying to control investor and media relations for Anglo-Swedish pharma major AstraZeneca remains an unenviable task, with leaks now appearing to suggest that chief executive Pascal Soriot is staying. 24 July 2017
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze